[go: up one dir, main page]

NO20092400L - 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) indole compounds and their use as 5-HT6 Ligands - Google Patents

4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) indole compounds and their use as 5-HT6 Ligands

Info

Publication number
NO20092400L
NO20092400L NO20092400A NO20092400A NO20092400L NO 20092400 L NO20092400 L NO 20092400L NO 20092400 A NO20092400 A NO 20092400A NO 20092400 A NO20092400 A NO 20092400A NO 20092400 L NO20092400 L NO 20092400L
Authority
NO
Norway
Prior art keywords
disorders
pharmaceutically acceptable
compounds
heterocyclyl
alkyl
Prior art date
Application number
NO20092400A
Other languages
English (en)
Other versions
NO341958B1 (no
Inventor
Rama Sastri Kambhampati
Venkateswarlu Jasti
Nirogi Venkata Satya Ramakrishna
Amol Dinkar Deshpande
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of NO20092400L publication Critical patent/NO20092400L/no
Publication of NO341958B1 publication Critical patent/NO341958B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives nye 4-(heterosyklyl)alkyl-N- (acetylsulfonyl)indolforbindelser med formel (I), deres derivater, stereoisomerer, deres farmasøytisk akseptable salter og farmasøytisk akseptable preparater inneholdende disse. Det beskrives videre en fremgangsmåte for fremstilling av de ovenfor nevnte nye forbindelser, deres derivater, deres stereoisomerer, deres farmasøytisk akseptable salter og farmasøytisk akseptable preparater inneholdende disse. Disse forbindelser er nyttige ved behandling av forskjellige forstyrrelser som er relatert til 5-HT6-reseptorfunksjoner. Spesifikt er forbindelsene ifølge oppfinnelsen også nyttige ved behandling av forskjellige CNS-forstyrrelser, hematologiske forstyrrelser, spiseforstyrrelser, sykdommer assosiert med smerte, respiratoriske sykdommer, genitourologiske forstyrrelser, kardiovaskulære sykdommer og cancer.
NO20092400A 2007-01-08 2009-06-24 4-(heterosyklyl)alkyl-n-(arylsulfonyl)indolforbindelser og deres anvendelse som 5-HT6-ligander NO341958B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN44CH2007 2007-01-08
PCT/IN2007/000311 WO2008084491A1 (en) 2007-01-08 2007-07-26 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands

Publications (2)

Publication Number Publication Date
NO20092400L true NO20092400L (no) 2009-10-02
NO341958B1 NO341958B1 (no) 2018-03-05

Family

ID=38819780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092400A NO341958B1 (no) 2007-01-08 2009-06-24 4-(heterosyklyl)alkyl-n-(arylsulfonyl)indolforbindelser og deres anvendelse som 5-HT6-ligander

Country Status (17)

Country Link
US (1) US20100041669A1 (no)
EP (1) EP2121602B1 (no)
JP (1) JP2010515673A (no)
KR (1) KR101176894B1 (no)
CN (1) CN101563321B (no)
AU (1) AU2007343062B2 (no)
BR (1) BRPI0718736A2 (no)
CA (1) CA2672190C (no)
DK (1) DK2121602T3 (no)
EA (1) EA016015B1 (no)
ES (1) ES2533902T3 (no)
IL (1) IL199300A (no)
MX (1) MX2009006757A (no)
NO (1) NO341958B1 (no)
NZ (1) NZ578281A (no)
WO (1) WO2008084491A1 (no)
ZA (1) ZA200904200B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318725B2 (en) 2008-09-17 2012-11-27 Suven Life Sciences Limited Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
EP3083588B1 (en) 2013-12-20 2020-12-09 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic compounds and their application in pharmaceuticals
JP6515175B2 (ja) * 2014-07-08 2019-05-15 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． 芳香族ヘテロ環誘導体及びその医薬的適用
EP3530651A1 (en) * 2018-02-21 2019-08-28 Adamed sp. z o.o. Indole and benzimidazole derivatives as dual 5-ht2a and 5-ht6 receptor antagonists
CN111233736B (zh) * 2020-03-16 2021-07-16 东莞市东阳光新药研发有限公司 芳杂环类衍生物的盐及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820113D0 (en) * 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
BR0115102B1 (pt) * 2000-11-02 2013-11-26 Compostos 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis e composição compreendendo os mesmos
YU96103A (sh) * 2001-06-07 2006-08-17 F.Hoffmann-La Roche Ag. Novi derivati indola sa afinitetom za 5-ht6 receptor
AU2003237599B2 (en) * 2002-11-28 2009-06-18 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
SE0302760D0 (sv) * 2003-10-20 2003-10-20 Biovitrum Ab New compounds
ES2398299T3 (es) * 2006-07-03 2013-03-15 Proximagen Ltd. Indoles como moduladores de 5-HT6

Also Published As

Publication number Publication date
DK2121602T3 (en) 2015-04-07
EA200970554A1 (ru) 2009-12-30
HK1135986A1 (en) 2010-06-18
JP2010515673A (ja) 2010-05-13
CN101563321A (zh) 2009-10-21
NZ578281A (en) 2011-01-28
EA016015B1 (ru) 2012-01-30
WO2008084491A1 (en) 2008-07-17
AU2007343062B2 (en) 2011-02-10
ES2533902T3 (es) 2015-04-15
IL199300A (en) 2014-03-31
EP2121602B1 (en) 2015-03-18
AU2007343062A1 (en) 2008-07-17
NO341958B1 (no) 2018-03-05
CN101563321B (zh) 2012-05-30
BRPI0718736A2 (pt) 2014-03-25
MX2009006757A (es) 2009-06-30
KR20090096513A (ko) 2009-09-10
KR101176894B1 (ko) 2012-08-30
US20100041669A1 (en) 2010-02-18
CA2672190A1 (en) 2008-07-17
ZA200904200B (en) 2010-10-27
EP2121602A1 (en) 2009-11-25
CA2672190C (en) 2013-02-05

Similar Documents

Publication Publication Date Title
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
EA200870373A1 (ru) Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
PH12013501594A1 (en) Substituted indazole derivatives active as kinase inhibitors
NO20074781L (no) 4-Oksokinazolin-3-ylbenzamidderivater for behandling av cytokinsykdommer
GB2454615A (en) Antidiabetic azabicyclo (3.1.0) hexan compounds
EA201270492A1 (ru) Соединения для лечения дислипидемии и связанных с ней заболеваний
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
TW201000488A (en) Heterocyclic derivatives
NO20082445L (no) Neuropeptid-2 reseptor-agonister
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
PH12013501393A1 (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
NO20092400L (no) 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) indole compounds and their use as 5-HT6 Ligands
NO20092067L (no) 5-(heterosyklyl)alkyl-n- (arylsulfonyl)indolforbindelserog deres anvendelse som 5-HT6-ligander
MX2009002906A (es) Derivados de piridina para el tratamiento de trastornos metabolicos relacionados con la resistencia a insulina o hiperglicemia.
ATE513810T1 (de) Aminoalkoxy-aryl-sulfonamidverbindungen und ihre verwendung als 5-ht6-liganden
ATE518833T1 (de) Aminoarylsulfonamidverbindungen und ihre verwendung als 5-ht6-liganden
NO20090193L (no) Substituerte heterocykliske etere og anvendelse derav i CNS forstyrrelser
MX2007000576A (es) Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias.
UA88910C2 (ru) Гетероциклические соединения для предотвращения или ослабления симптомов заболеваний, которые лечатся коноплей, и способы их получения
CY1110087T1 (el) Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο
ATE412416T1 (de) Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür
WO2010012806A3 (en) Substituted indole sulfonamide compounds, their preparation and use as medicaments

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees